Andrew Boardman

AB

Statistics

Publications

1

Citations

44

H-Index

1

Active since

2021

Andrew Boardman is an author at Heptares Therapeutics (United Kingdom) specializing in drug discovery, systems-level drug discovery, and machine learning drug repurposing.

Publications per year

2021–2021

1

Publications

1